NJ A3630

Requires practitioners prescribing opioids for chronic pain (3+ consecutive months) to conduct baseline urine drug testing for new patients and random urine screens at least once every 12 months to monitor compliance and detect non-prescribed drug use

Mandates practitioners advise patients (or parents/guardians for minors) about the availability of opioid antidotes when prescribing controlled substances for chronic pain

Requires referral to a pain management or addiction specialist if treatment objectives are not being met during chronic pain management with opioids

Amends the definition of "chronic pain" to mean pain persisting for three or more consecutive months that continues after reasonable medical efforts to relieve it, rather than the previous definition of pain that "persists or recurs for more than three months"

Authorizes practitioners to prescribe up to a 90-day supply via implantable infusion pumps for pain management in patients with cancer, intractable pain, or terminal illness